Possible Role for Ipilimumab in Metastatic Bladder Cancer, Study Suggests
MedPage Today,
Oncology/Hematology > Other Cancers Objective response rate of 33% better than that for nivolumab alone in CheckMate 275 trial…
Oncology/Hematology > Other Cancers Objective response rate of 33% better than that for nivolumab alone in CheckMate 275 trial…
Doctors may recommend nivolumab (Opdivo) adjuvant for some people with bladder cancer.
Until 5 years ago, systemic therapeutic options for urothelial carcinoma, the most common form of bladder cancer, had been…
BACKGROUND: Patients with metastatic urothelial carcinoma have a dismal prognosis and few treatment options after first-line…